C-reactive protein (CRP) is the most acute-phase reactant serum protein of inflammation and a strong predictor of cardiovascular disease. Its expression is associated with atherosclerotic plaque instability and the formation of immature micro-vessels. We have previously shown that CRP up-regulates endothelial-derived Notch-3, a key receptor involved in vascular development, remodelling and maturation. In this study, we investigated the links between the bioactive monomeric CRP (mCRP) and Notch-3 signalling in angiogenesis. We used in vitro (cell counting, wound-healing and tubulogenesis assays) and in vivo (chorioallantoic membrane) angiogenic assays and Western blotting to study the angiogenic signalling pathways induced by mCRP and Notch-3 activator chimera protein (Notch-3/Fc). Our results showed an additive 
Introduction
Deregulated angiogenesis is a key hallmark of vascular pathological conditions such as atherosclerotic plaque development, myocardial infarction and tumour growth [1] . Restoring perfusion to ischemic organs or limbs is a goal of therapeutic angiogenesis, while success with anti-angiogenic therapy has been a target for treatment of tumours. However, in both cases, there has been limited success to date, due to lack of a full understanding of the complex mechanisms underlying angiogenesis and vascular remodelling.
It has been reported that monomeric C-reactive protein (mCRP) may be linked with plaque instability at the carotid bifurcation, thus contributing to haemorrhage [2] . We have previously detected mCRP expression in the adventitia and intimal neovessels from complicated regions of unstable carotid plaques [3] and of note, the formation of immature blood vessels, associated with ischemic stroke, has also been linked with over-expression of mCRP [4] . Furthermore, we have demonstrated in vitro and in vivo pro-angiogenic effects of mCRP via the ERK/MAPK pathway in association with a concomitant increase of Notch-3 gene expression [5] , highlighting possible crosstalk between inflammatory cytokines and transcription factors essential for angiogenesis. Thus, the aim of this study was to specifically assess whether mCRP and Notch-3 signalling act together in a cooperative manner during angiogenesis and to establish the signalling pathways that link their coordination.
Mainly produced by the liver under interleukin-6 stimulation, CRP is composed of five identical non-covalently associated non-glycosylated globular proteins of 23-kDa subunits arranged symmetrically around a pore [6, 7] . The pro-bioactive component of the pentameric CRP (pCRP) is mainly due to its monomeric form, mCRP which appears from pCRP dissociation by its contact to the plasma membrane of apoptotic cells or activated platelets in atherosclerotic plaques [8, 9] or under drastic conditions (low pH, absence of calcium, increased temperature and urea chelation) [10] . It binds to the cells through its main Fcγ receptors (i.e. CD16, CD32 and CD64) with differential affinity on different cell types [11, 12] . As a prognostic marker of the development and progression of vascular disease, CRP plays a pivotal role by exerting direct modulatory effects on vascular cell functions including inflammatory, angiogenic and thrombotic properties [5, 7, 9] .
The Notch receptor plays a central role in the main stages of blood vessel formation including blood vessel remodelling, stabilization and maturation [13, 14] . Notch proteins (Notch-1, Notch-2, Notch-3, Notch-4) are single transmembrane receptors whose signalling is initiated by the interaction of one of the five canonical membrane-bound ligands (Jagged1, Jagged2 and Deltalikes Dll1, Dll3, and Dll4) expressed on the surface of adjacent cells. This interaction leads to a proteolytic cleavage by γ-secretase complex that releases the Notch intracellular domain (NICD) in the cytoplasm, and subsequent translocation to the nucleus [15] . Inside the nucleus, NICD binds the transcriptional factor CBF-1/Suppressor of hairless Lag-1 (CSL) and consequently activates target gene expression resulting in cell fate decisions such as arterial/venous cell differentiation, proliferation, and survival/apoptosis during embryonic and postnatal development of many organs including the vasculature [15] [16] [17] . The function of Notch-3 as an essential component of vascular formation has been demonstrated in patients with stroke, where Notch-3 mutations cause the cerebral autosomal dominant arteriopathy known as CADASIL, a neurological disease characterized by vascular smooth muscle cell pathology and progressive brain ischemia due to an underlying arteriopathy [18, 19] . In addition to the classical role of NICD activating downstream target genes, Notch receptor activation triggers signalling which cross-talks with phosphatidylinositol 3-kinase (PI3K)/Akt, extracellular signal-regulated kinase (ERK)/ mitogen-activated protein kinase (MAPK), Src and Ras pathways [20, 21] .
We hypothesize that, through the elevation of mCRP-induced Notch-3 gene expression level, mCRP and Notch-3 act in a co-operative manner in vascular endothelial cells, to exert a role in the remodelling and maturation of the vascular development; this study aims to investigate the endothelial angiogenic response and the common signalling pathways involved. The findings could have an impact on developing strategies to attenuate plaque rupture and to reduce the risk of haemorrhage in inflammatory vascular diseases.
Materials and Methods

Reagents
Recombinant form of mCRP (0.5 mg/mL in 25 mM NaPBS, pH 7.4) was produced in the laboratory of Dr L.A. Potempa as previously described [22] . The mCRP solution contained an endotoxin concentration lower than 0.125 EU/mL and all cell culture medium was endotoxinfree. Notch-3/Fc chimeric protein was purchased from R&D systems (Abingdon, UK). All secondary antibodies conjugated to horse-radish peroxidase were provided by DakoCytomation (Glostrup, Denmark). Rat tail collagen type I and growth factor-reduced Matrigel TM were purchased from Becton Dickinson (Bredford, MA). Pharmacological inhibitors for PI3K pathway (LY294002) and for γ-secretase activity (DAPT) were provided by Santa Cruz biotechnology (Middlesex, UK). All other reagents and items were purchased from SigmaAldrich (Dorset, UK).
Culture of bovine aortic endothelial cells and smooth muscle cells
Bovine aortic endothelial cells (BAEC) were isolated as previously described [23] and seeded in 75-cm 2 flasks (Nunc, Fischer Scientific, Loughborough, UK) pre-coated with 0.1% gelatine and cultured in Dulbecco's Modified Eagle Medium (Lonza, Cambridge, UK) supplemented with 20% heat-inactivated fetal bovine serum (FBS, Cambrex, Hertfordshire, UK), 2 mM glutamine and 1% antibiotics (100 µg/mL streptomycin, 100 U/mL penicillin), defined as complete medium. Bovine aortic smooth muscle cells (BASMC) were supplied by Health Protection Agency Culture Collections (Public Health England, Salisbury, UK) and cultured in specialized medium for smooth muscle cells (Lonza, UK), supplemented with 6% serum and 1% antibiotics.
Both cell types were incubated at 37°C in a saturated air humidity/5% CO 2 -incubator, passaged every 2-3 days, using enzymatic digestion with 0.05% trypsin / 0.02% EDTA and split at a ratio of 1:2 or 1:3. At confluence, EC and SMC were identified by their typical cobblestone morphology and "hill and valley" configuration, respectively. The cells were used throughout the study between passages 4 and 9.
RNA extraction and reverse transcriptase (RT) -polymerase chain reaction (PCR)
Extraction of total RNA from BAEC was performed and used to monitor the mRNA expression of bovine Notch-3 (XM_003582382.1). Complementary DNA (cDNA) was produced from total RNA extracts in two steps as previously described [24] . Primer pairs (Invitrogen -Life technologies, Paisley, UK) were selected by software Primer3 and the sequences used were:
5' AGC CAC TGT GAG CAG GAG AT 3' (sense) and 5' TGG AGG ACA GGA GCA GAG AT 3' (anti-sense) for bovine Notch-3, corresponding to a 220 bp-length fragment. The genespecific primer pairs used for PCR were optimized for cycle number (35 cycles) and t m (59°C).
PCR products were analysed by 1.5% agarose gel electrophoresis. Bovine ribosomal protein S14 gene expression was used as an internal standard.
Endothelial cell proliferation assay
BAEC (2 x 10 4 cells/well) were seeded in complete medium in 24-well plates (Nunc). After 4 h incubation, the medium was replaced with serum-poor medium (SPM; medium supplemented with 2.5% FBS) with or without 5 µg/mL mCRP and ± 20 ng/mL Notch-3/Fc, in the presence or absence of pharmacological inhibitors DAPT (γ-secretase inhibitor; 10 µM) and LY294002
(PI3K/Akt pathway inhibitor; 10 µM). Each condition was performed in triplicate, with SPM or 0.05% dimethyl sulfoxide (DMSO)-treated cells used as negative controls. After 72 h incubation, the cells were detached in 250 µL of 0.05% trypsin / 0.02% EDTA and then each cell suspension was diluted in 10 mL of isotonic solution prior to counting using a Beckman-Coulter counter (London, UK). PFA for 15 min and the closed areas, used as a parameter for quantification of tubulogenesis [25] , were counted in 5 random fields.
Endothelial cell migration -wound recovery assay
Western blot analysis
For the study of intracellular protein expression, BAEC (10 5 cells/well) were seeded in complete medium in a 24-well plate. After 48 h incubation, the medium was renewed with SPM for further 24 h incubation, and then 5 µg/mL mCRP ± 20 ng/mL Notch-3/Fc were added for 10 min stimulation at 37°C. After fast washing in cold PBS, cells were lysed with 120 µL/well of icecold radioimmunoprecipitation (RIPA) buffer (pH 7.5) as previously described until the transfer of the proteins onto nitrocellulose filters [5] . For the study of adhesion molecule expression, cocultured BAEC/SMC (10 5 cells/well) were seeded on collagen gel in complete medium in a 24-well plate. After 4 h incubation, the medium was replaced with SPM with or without 5 µg/mL mCRP ± 20 ng/mL Notch-3/Fc. Each condition was performed in duplicate and complete medium or 0.05% DMSO-treated cells were used as negative controls. After 3 days of culture, the cells were washed with cold PBS and then lysed for 1 h on ice with 80 µL/well of lysis buffer containing 50 mM tris HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Triton X-100 and 1 µM leupeptin. After protein estimation using Bradford protein assay (Biorad, Munchen, Germany), 100 µg of proteins were mixed with 2X Laemmli sample buffer then were separated by 10% SDS-PAGE and electroblotted (Hoefer, Bucks, UK)
onto nitrocellulose filters (1 h). Nitrocellulose filters were blocked for 1 h at room temperature in TBS-Tween (pH 7.4) containing 1% BSA, and stained with the following primary antibodies diluted in the blocking buffer, overnight at 4°C on a rotating shaker: goat polyclonal antibodies to total Akt (t-Akt, 1:1000), rabbit polyclonal antibodies to p-Akt (Thr308, 1:500) and mouse polyclonal antibody to β-tubulin from Santa Cruz Biotechnology, rabbit polyclonal antibodies to VE-cadherin (1:1000) from Upstate Biotechnology (Lake Placid, NY) and mouse monoclonal antibodies to N-cadherin (1:1000) from Novus Biologicals (Cambridge, UK). After washing (5x 10 min in TBS-Tween at room temperature) filters were stained with either rabbit anti-goat, goat
anti-rabbit or rabbit anti-mouse horse-radish peroxidase-conjugated secondary antibodies diluted in TBS-Tween containing 5% de-fatted milk (1:1000, 1 h, room temperature) with continuous mixing. After a further 5 washes in TBS-Tween, proteins were visualized by ECL (Geneflow Ltd, Staffordshire, UK) chemiluminescent detection and the image captured by Syngene imaging system was analysed using GeneSnap software (Syngene, Cambridge, UK).
Chick chorio-allantoic membrane (CAM) assay
Fertilised Dekalb White hen's eggs (Henry Stewart Ltd, Louth, Lincolnshire, UK) were received at day 0 and incubated in a humidified egg incubator (R-COM, Powys, UK) for 6 days. After this incubation, the location of the embryo was checked using an egg candle, then the opposite side of the shell was chosen to punch a small hole, 3 mL of albumin were aspirated using a 25-G hypodermic needle and a window was carefully created over embryonic blood vessels. Sterile
Whatman filter papers with a 6 mm diameter hole in the centre were placed onto the CAM and the following 5 µL treatments were administered via the middle of the hole: sterile PBS (control), 0.5 mg mCRP, 80 ng Notch-3/Fc and the addition of mCRP to Notch-3/Fc in the presence or absence of 10 µM LY294002 or 10 µM DAPT. Each condition was performed in triplicate and complete medium or 0.05% DMSO-treated cells were used as negative controls.
After 3 days of incubation, the vessels were photographed using a Leitz dissecting microscope at a magnification of x40. Angiogenesis was quantified by measuring the vessel length, the vessel area using Image J software and by counting the vessel branch-points per 0.1 mm 2 density. The experiments were independently repeated five times for each condition.
Tri-dimensional sprout formation assay: spheroids embedded in collagen gel
BAEC/SMC co-culture spheroids were generated by mixing 125 µL of 3x10 5 /ml of BAEC added to 125 µL of 3x10 5 /ml of BASMC with 15 mL of 1.2% methylcellulose (4000 Cp viscosity).
Then 150 µL of the 15 mL mixture were distributed in each well of 96-well Greiner® plates.
After 2 days of incubation at 37°C and for each experimental condition, 48 well-formed spheroids were collected, centrifuged at 400 g for 3 min and re-suspended in 250 µL of methylcellulose with or without either 5 µg/mL mCRP, 20 ng/ml Notch-3/Fc or both. The collagen solution (250 µL of 2 mg/mL) which had been previously neutralized with 0.1N NaOH was added to the spheroid mixture. Each collagen-spheroid mixture was equally distributed in a 24-well plate, in duplicate for each condition. After 2 days of incubation, sprouting occurred from the spheroid core and to measure the length of the sprouts, the spheroids were fixed with 4% PFA for 15 min. The sprout length was estimated using the software Image J from 5 spheroids with a similar sized core.
Transmission electronic microscopy
The spheroids were fixed overnight with 2% formaldehyde/2 % glutaraldehyde in 0.1M cacodylate buffer (pH 7.2) and post-fixed with reduced osmium (1% OsO 4 and 1.5% K 4 Fe(CN) 6 ) for 1 h, then with 1% tannic acid in 0.1 M cacodylate buffer for 1 h and finally with 1% uranyl acetate in water. The spheroids were dehydrated in a battery of alcohols, infiltrated with TAAB LV resin and polymerized for 24 h at 60°C. Ultrathin sections (70 nm) were cut with a Leica Ultracut S ultramicrotome and placed on formvar/carbon coated slot grids. The grids were observed in a Tecnai 12 Biotwin transmission electronic microscopy at 80kV.
Statistics
Results were expressed as mean ± standard deviation (SD). Experimental points were performed with a minimum of three independent experiments. An unpaired Student's t-test was used for comparison of two groups. A value of P < 0.05 was considered significant. Moreover, the combined factors demonstrated an additive effect (2.65-fold, p = 0.0006, Figure   2Civ ) with a significant difference when compared to each stimulus alone (Figure 2Cv ).
Results
mCRP and
mCRP and Notch-3/Fc enhance p-Akt expression
Recently identified as Notch-3 downstream target cytoplasmic protein [21] , we assessed the 
LY294002 and DAPT attenuate mCRP and Notch-3 pro-angiogenic activities in vitro
Using two pharmacological inhibitors of PI3K/Akt and of Notch signalling activation in all in vitro angiogenic assays (Figure 4) , we demonstrate that the addition of LY294002 (10 µM) prevents both mCRP-and Notch-induced cell proliferation ( Figure 4A ), compared to control.
The addition of DAPT prevents Notch-3/Fc positive mitogenic effect but not mCRP effects. The addition of the two inhibitors LY294002 and DAPT gave similar results on cell proliferation to those observed with LY294002 alone ( Figure 4A ). Blocking PI3K signalling with LY294002
significantly decreased mCRP-and Notch-3/Fc-induced vascular cell migration ( Figure 4B ), while addition of DAPT inhibited Notch-3/Fc-induced cell migration but had no effect on mCRP-induced endothelial cell migration ( Figure 4B ). As in the case for cell proliferation, the addition of the combined inhibitors decreased mCRP-and Notch-3/Fc-induced endothelial cell migration in a similar manner to that produced by LY294002 alone ( Figure 4B ). In contrast, DAPT significantly inhibited both mCRP and Notch-induced tube formation whereas in the presence of LY294002 (alone or added to DAPT), no change in tubulogenesis was observed after mCRP or Notch treatment ( Figure 4C ). Of note, the positive effects on tube formation caused by combined mCRP/Notch-3/Fc treatment was retained even after addition of LY294002 or DAPT but the pro-angiogenic effect was abolished when the inhibitors were added together ( Figure 4C ).
mCRP and Notch3/Fc promotes angiogenesis in vivo
Monomeric CRP and Notch signalling activator chimera protein Notch-3/Fc were tested on 6-day-old chick chorio-allantoic membranes, to assess the formation of neo-vessels over Figure 5B ) and number of branch-points by 3.5-fold (p = 0.001, Figure   5B ). Notch-3/Fc (80 ng/5 µl, Figure 5Aiii ) enhanced vessel number by 1.45-fold (p = 0.003, Figure 5B ) and vessel branch-point number by 1.8-fold (p = 0.018, Figure 5B ). The combined effect of mCRP with Notch-3/Fc (Figure 5Aiv ) increased both the vessel number, branch-points (
Figure 5B), and the vessel area density by 3.15-fold (p = 0.001, Figure 5C ).
The formation of neo-blood vessels of the chorio-allantoic membrane induced by combined mCRP with Notch-3/Fc was inhibited by DAPT and more markedly inhibited by LY294002
( Figure 5D ). Blocking Notch signalling using DAPT in cells with the combined treatment of mCRP and Notch-3/Fc resulted in a 40% decrease of the vessel number density ( Figure 5D ). The addition of LY294002 to combined mCRP/Notch-3/Fc treatment inhibited the angiogenic process by 80% ( Figure 5D ). However surprisingly, the combination of both inhibitors DAPT and LY294002 added to the combined mCRP and Notch-3/Fc treatment, prevented the strong anti-angiogenic response and decreased the vessel number density by only 25%, when compared to the vascular network formed by the mCRP/Notch-3/Fc treatment in the absence of inhibitors ( Figure 5D ). To highlight the adhesive structural proteins that may be involved in mCRP and Notch-induced sprouting angiogenesis and vascular stability, we used Western blot analysis to detect VEcadherin and N-cadherin in lysates of co-cultured vascular cells after 3-day incubation in collagen gel ( Figure 6D ). mCRP up-regulated VE-cadherin expression while Notch-3/Fc downregulated its expression, compared to the control untreated co-cultured vascular cells ( Figure   6D ). N-cadherin expression was up-regulated by both mCRP and Notch-3/Fc and its induction was stronger when mCRP was combined with Notch-3/Fc. In contrast, VE-cadherin expression was undetectable in the presence of both mCRP and Notch-3/Fc ( Figure 6D ).
mCRP with
Discussion
In this study, we provide the first insight into the combined effects of monomeric C-reactive protein (mCRP) and Notch-3 signalling activator chimera protein (Notch-3/Fc) through the PI3K/Akt survival pathway, leading to increased angiogenesis. In addition, we showed that the Notch signalling activator Notch-3/Fc in combination with mCRP contributes to the enhancement of the thickness of vascular sprouts embedded in collagen gel, and is associated with a concomitant increase of N-cadherin expression and a down-regulation of VE-cadherin protein expression. Thus, combined mCRP with Notch-3 might promote and stabilize vessel formation whilst reducing the risk of haemorrhage from immature blood vessels or unstable plaque in vascular diseases.
CRP is an important acute-phase reactant protein in patients and a strong predictor of cardiovascular disease. Associated with the contribution of inflammation to the pathogenesis of atherosclerosis, CRP expression has been correlated with unstable plaque in vascular diseases and an increased risk of haemorrhage [3] . Furthermore, its bioactive monomeric form (mCRP) has been shown to be abundantly expressed in immature micro-vessels located in peri-infarcted regions of patients with acute ischemic stroke [4] . Although Notch-3 receptor is widely known to be expressed mainly by mural cells and to contribute to blood vessel stability, we previously reported an up-regulation of Notch-3 gene expression by mCRP in cultured aortic endothelial cells [5] .
Here, a purified and endotoxin-free mCRP solution, at the concentration of 5 µg/mL corresponding to the CRP plasma concentration of patients with high cardiovascular risk, has been used to successfully stimulate angiogenesis, as shown by increased endothelial cell proliferation, migration and tube formation. Previously, CRP biological activities have been subjected to many controversies because of the use of commercial CRP solutions containing contaminants such as endotoxin and sodium azide as causal agents of these effects [26] . In this study, we used an endotoxin-free and purified recombinant mCRP, demonstrated to be the bioactive form of the CRP [3, 4] . Many studies reported that CRP induces endothelial cell dysfunction including inhibition of cell proliferation, increased apoptosis, and reduced expression of eNOS; however, Taylor and her colleagues demonstrated that these effects were in fact caused by the contaminants present in the commercial CRP solution [26] . Using vascular cells isolated from thoracic aortas and the coronary circulation, Cirillo and his colleagues reported that a commercial endotoxin-free and purified CRP increased endothelial cell proliferation in a dose-dependent manner (from 20 µg/mL) through ERK/MAPK pathway [27] .
In support of these data, we directly report that the bioactive mCRP induced cell proliferation at lower concentration (i.e. 5 µg/mL) than previously used. Our present study showing mCRP proangiogenic effects using BAEC support and extend our previous studies using human artery and human aortic endothelial cells [5] . In addition, many clinical observations reported that increased atherosclerotic intraplaque neovascularization plays an important role in plaque progression, plaque instability, and rupture of plaque with risk of haemorrhage [28] . These results reinforce the correlation between mCRP overexpression and unstable plaques through mCRP proangiogenic effects. and Notch-3 signalling-promoted angiogenesis was also confirmed using the in vivo CAM assay.
The strongest inhibition of angiogenesis induced by the combined effect of mCRP with Notch-3/Fc was obtained after the blockade of PI3K/Akt survival pathway ( Figure 7) . Surprisingly, the blockade of γ-secretase activity and PI3K/Akt pathway in the CAM assay did not fully inhibit the pro-angiogenic effects induced by the combined mCRP with Notch-3/Fc. This finding suggests that activation of other angiogenic signalling pathways occur in compensation to the blockade of both mCRP and Notch-3 signalling pathways.
To get a better understanding of the cell behaviour and the vascular cell interactions involved during sprouting angiogenesis, tri-dimensional BAEC/SMC co-culture spheroids were embedded in type I collagen gel. Using transmission electron microscopy (TEM), some differences in vascular cell organization were highlighted during the sprouting angiogenesis showing discontinuous and continuous vascular sprout structures induced by mCRP and Notch-3/Fc, respectively. Regarding the continuous vascular sprout structures induced by Notch-3/Fc, it is widely defined that heterotypic Notch signalling from endothelial cells to smooth muscle cells is critical for vessel stabilization and maturation [42] . In addition, endothelial cell autonomous Notch signalling regulates endothelial cell branching during sprouting angiogenesis [32] . The discontinuous vascular system induced by mCRP consists of gaps between adjoining cells, suggesting mCRP could be a key contributor to leakage because of the lack of interactions between the cells. A closer analysis of vascular cell organization during sprouting angiogenesis using TEM has revealed for the first time that mCRP induced the formation of finer filopodia displayed by some vascular cells. Using a human pro-monocytic cell line (U937), Ciubotaru and colleagues [43] have described an association of this aspect of filopodia formation and cell polarization with the increase of CRP expression which reflected its potential role in the cytoskeletal rearrangement.
To study the mechanism underpinning vascular cell interactions associated with mCRP and Notch-induced sprouting angiogenesis, we targeted two transmembrane adhesion molecules:
vascular endothelial (VE)-cadherin, known to play a critical role in vascular barrier integrity [44] , and neural (N)-cadherin, thought to be essential for interactions between endothelial and mural cells with stabilization of nascent blood vessels by mural cells [45] . Using aortic EC and SMC co-cultured on type I collagen gel, followed by Western blotting we showed that mCRP but 
